Debate 9: Optimal Adjuvant Therapy in Pancreatic Cancer? - Intensified chemotherapy

Filmed on location in New York during the Great Debates and Updates in GI Malignancies 2015, this webcast is part of a series that provides educational discussions on controversial areas in the management of gastrointestinal malignancies. Join us as nationally-recognized thought leaders take opposing sides on topics of clinical interest, and present updates in standards of care.

In this presentation, Dr. Eileen O'Reilly argues that a more intensified chemotherapy regimen (either Gem/nab-paclitaxel or FOLFIRINOX) required in the adjuvant setting for pancreatic cancer.

© 2015 Imedex, LLC.